Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Hemoglobin A1c (HbA1c) Testing Market Growth From $2.23 Billion In 2026 To $3.31 Billion By 2030 At A CAGR Of 10.3%

Demand for hemoglobin A1c (HbA1c) testing has seen considerable expansion lately. Projections show this market will advance from $2.02 billion in 2025 to $2.24 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 10.5%. Factors contributing to this expansion during the past period include a worldwide increase in diabetes cases, greater engagement with continuous glucose monitoring approaches, the broadening of diagnostic laboratory capabilities, elevated consciousness regarding diabetes screening practices, and the broader acceptance of HbA1c as the benchmark for diagnosis.

The market for hemoglobin A1c (HbA1c) testing is poised for substantial expansion in the coming years, with projections indicating a rise to $3.31 billion by 2030, driven by a compound annual growth rate of 10.3%. This anticipated growth is fueled by several key factors, including the increasing use of at-home diabetes management tools, greater investment in networked diagnostic technologies, the proliferation of proactive health programs, a heightened emphasis on early identification of diabetes, and a growing need for swift diagnostic capabilities. Prominent trends expected to shape this period involve a greater acceptance of point-of-care HbA1c testing equipment, a surge in demand for mobile and domestically used HbA1c analysis devices, the expanding integration of wireless and connected testing platforms, advancements in highly precise laboratory-based HbA1c methods, and an intensified focus on achieving standardization and diagnostic precision.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18632&type=smp

Hemoglobin A1c (HbA1c) Testing Market Growth Momentum: Which Factors Are Influencing Demand?

The projected expansion of the hemoglobin A1c (HbA1c) testing market is largely attributed to the escalating incidence of diabetes, a chronic condition marked by the body’s inability to manage blood sugar effectively due to inadequate insulin or resistance. This rise in diabetes cases is fueled by dietary habits, particularly the excessive intake of processed foods and sweetened beverages, alongside inactive lifestyles with limited exercise. Furthermore, an aging demographic and a familial predisposition to diabetes heighten the likelihood of developing the disease. HbA1c tests are instrumental in tracking sustained blood glucose control for diabetic individuals, by assessing average sugar levels over a two to three-month period. To illustrate, data released in June 2023 by The Lancet, a prominent publishing entity in the UK, forecasts a surge in global diabetes cases from 529 million in 2021 to an estimated 1.3 billion by the year 2050, underscoring the direct correlation between increased diabetes prevalence and the anticipated growth within the HbA1c testing sector.

Hemoglobin A1c (HbA1c) Testing Market Segment Landscape And Growth Potential

The hemoglobin a1c (hba1c) testing market covered in this report is segmented –

1) By Testing Method: Laboratory-Based Testing, Point Of Care (PoC) Testing

2) By Product Type: Instruments, Reagents, Kits

3) By Technology: Immunoassays, Chromatography, Enzymatic Assays, Boronate Affinity Chromatography, High Performance Liquid Chromatography

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Homecare Settings

Subsegments:

1) By Laboratory-Based Testing: High-Performance Liquid Chromatography (HPLC) Testing, Ion-Exchange Chromatography, Capillary Electrophoresis

2) By Point Of Care (PoC) Testing: Fingerstick Testing Devices, Portable Hba1c Analyzers, Handheld Hba1c Test Kits

Hemoglobin A1c (HbA1c) Testing Market Trends Reshaping Industry Growth

In the market for hemoglobin A1c (HbA1c) testing, leading enterprises are prioritizing innovations in diagnostic technology, particularly the development of at-home HbA1c testing kits. These advancements aim to provide individuals with more convenient, precise, and readily available methods for the early identification and ongoing management of diabetes. The concept of HbA1c home tests involves diagnostic kits designed for personal use, enabling users to ascertain their average blood glucose levels over a preceding 2-3 month period, which is crucial for effective diabetes monitoring and control. Illustrating this trend, Hurdle Health, a company based in the United States committed to delivering cutting-edge healthcare solutions and diagnostic instruments for managing long-term illnesses, introduced its Hemoglobin A1c (HbA1c) Test in February 2023. This newly released at-home blood testing kit empowers adults to screen for and monitor their diabetes status, thereby supporting Chronomics’ overarching goal of increasing access to diagnostic testing and improving overall health results via direct-to-consumer platforms.

Hemoglobin A1c (HbA1c) Testing Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the hemoglobin a1c (hba1c) testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Tosoh Corporation, Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc, ARKRAY Inc, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Agappe Diagnostics Ltd, SEKISUI Diagnostics LLC, Helena Laboratories, Transasia Bio Medicals Ltd, EKF Diagnostics, Trinity Biotech plc, HemoCue AB, CPC Diagnostics Pvt Ltd, PTS Diagnostics, Menarini Diagnostics srl, Diazyme Laboratories Inc, Osang HealthCare Co Ltd, Eurolyser Diagnostica GmbH, DiaSys Diagnostic Systems GmbH

Access The Complete Hemoglobin A1c (HbA1c) Testing Market Report:

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report

Hemoglobin A1c (HbA1c) Testing Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the hemoglobin A1c (HbA1c) testing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin a1c (hba1c) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model